effect overlay
activetrials
Epilepsy
Epilepsy
RENAISSANCE 2

RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

HREC: 2025.173
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Sean Hosking
Funding: Commercial
Stroke
Stroke
International Registry for Iatrogenic CAA

International Registry for Iatrogenic Cerebral Amyloid Angiopathy (CAA)

HREC: 2025.159
Principal Investigator: Dr Chloe Mutimer
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
EMU: First Responder Helmet

Staged Workflow Assessment and Data Collection Study of the EMVision First Responder Brain Scanner in the Melbourne Mobile Stroke Unit

HREC: 2025.120
Principal Investigator: Dr Angela Dos Santos
Coordinator contact:
Funding: Commercial
Active Trials - Other
Peripheral Neuropathy
Immunovant CIDP Study

A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 

HREC: 2025.113
Principal Investigator: Dr Belinda Cruse
Coordinator contact: Kate Furlong
Funding: Commercial
Movement Disorders
Movement Disorders
exPDite for Parkinson's Disease

exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease

HREC: 2025.110
Principal Investigator: Dr Andrew Evans
Coordinator contact: Reena Chopra & Rebecca Ravenhill
Funding: Commercial